NMIN’s Scientific Director Dr. Christine Allen has named Dr. Warren Chan the new co-leader of NMIN’s Theme III: Diagnostics research team.
“I’m delighted that Dr. Chan has agreed to take on this role,” comments Dr. Allen. “He is a world renowned expert in diagnostics and an excellent role model for our trainees.”
Dr. Chan succeeds Dr. Shana Kelley, who stepped down from the role in June 2021, and joins forces with Dr. Gilbert Walker, who has been the Theme’s co-leader since the Network’s inception.
“I am excited to work with my NMIN colleagues and the broader community to advance nanotechnology-based diagnostics to help society,” says Dr. Chan.
Dr. Chan is a Professor and Director of the Institute of Biomedical Engineering at the University of Toronto and an NMIN investigator.
Dr. Chan received his B.S. degree from the University of Illinois in 1996, Ph.D. degree from Indiana University in 2001, and post-doctoral training at the University of California (San Diego). He moved to Toronto in 2002 to lead the Integrated Nanotechnology/Biomedical Sciences Laboratory.
His research interest is in the development and translation of nanotechnology for diagnosing and treating cancer and infectious diseases.
Dr. Chan’s multidisciplinary research program has generated affiliations with a number of different departments at the University of Toronto, including the Department of Materials Science and Engineering, the Terrence Donnelly Center for Cellular and Biomolecular Research Chemistry, and the Department of Chemistry and Chemical Engineering.
Dr. Chan has received the NSERC E. W. R. Memorial Steacie Fellowship, the BF Goodrich Young Inventors Award, the Lord Rank Prize Fund award in Optoelectronics (England), and the Dennis Gabor Award (Hungary). He is currently an Associate Editor of ACS Nano.
Watch the video of Dr. Chan delivering the NMIN Lecture:
The nanoparticle biological identity & protein corona